当前位置: X-MOL 学术Immun. Inflamm. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identification and validation of immune-related lncRNA prognostic signatures for melanoma
Immunity, Inflammation and Disease ( IF 2.493 ) Pub Date : 2021-06-02 , DOI: 10.1002/iid3.468
Bo Xiao 1 , Liyan Liu 1 , Aoyu Li 1 , Pingxiao Wang 1 , Cheng Xiang 1 , Hui Li 1 , Tao Xiao 1
Affiliation  

Melanoma is a highly aggressive malignant skin tumor as well as the primary reason for skin cancer-specific deaths. We first identified immune-related long noncoding RNA (lncRNA) prognostic signature and found potential immunotherapeutic targets for melanoma cancer.

中文翻译:

黑色素瘤免疫相关 lncRNA 预后特征的鉴定和验证

黑色素瘤是一种高度侵袭性的恶性皮肤肿瘤,也是皮肤癌特异性死亡的主要原因。我们首先确定了免疫相关的长非编码 RNA (lncRNA) 预后特征,并发现了黑色素瘤癌症的潜在免疫治疗靶点。
更新日期:2021-08-07
down
wechat
bug